Quantbot Technologies’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,027
Closed -$133K 1757
2025
Q2
$133K Buy
20,027
+280
+1% +$1.99K ﹤0.01% 1331
2025
Q1
$181K Buy
19,747
+9,931
+101% +$99.2K 0.01% 1149
2024
Q4
$103K Buy
+9,816
New +$116K ﹤0.01% 1191
2024
Q3
Sell
-20,588
Closed -$118K 1470
2024
Q2
$118K Buy
+20,588
New +$113K 0.01% 1089
2023
Q4
Sell
-5,600
Closed -$18.5K 1597
2023
Q3
$18.5K Buy
5,600
+900
+19% +$3.16K ﹤0.01% 1360
2023
Q2
$13.6K Buy
+4,700
New +$9.02K ﹤0.01% 1445

Other funds holding BVS

Quantbot Technologies's BVS Position: Q3 2025 in Review

Quantbot Technologies sold out of Bioventus (BVS) in Q3 2025, closing a stake of 20,027 shares — an estimated $133K sold.

Quantbot Technologies first reported a position in BVS in Q2 2023 and held it in 6 quarters. The position peaked at $181K in Q1 2025. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Quantbot Technologies reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 20,027 Bioventus shares in Q3 2025, an estimated $133K.
  • Quantbot Technologies first reported a position in Bioventus in Q2 2023 and held it in 6 quarters.
  • Quantbot Technologies's Bioventus position peaked at $181K in Q1 2025.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.